Elevai Labs, Inc. signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx (Precision Regenerative Exosome Technology) in topical skincare.
The potential collab could combine mitochondrial biology with Elevai’s human umbilical mesenchymal stem cell derived exosomes.
Elevai currently markets its proprietary ELEVAI E-Series which are peri-procedure topical exosome skincare products. Yuva Biosciences utilizes mitochondrial science to address signs of aging of hair, scalp, and skin. Yuva Biosciences has a platform that includes an AI model to rapidly screen huge numbers of natural compounds for their effectiveness in improving mitochondrial health.
“We are excited to partner with Yuva Biosciences in order to begin research and development of products that may incorporate the power of mitochondrial technology to further advance the potential of Elevai exosomes to address cosmetic skin and hair concerns associated with signs of aging,” says Jordan R. Plews PhD and CEO of ELEVAI Labs, in a news release.
“YuvaBio, in partnership with Elevai, is researching topical cosmetic applications that may limit the appearance of human aging and we believe this research and development partnership has the potential to commercialize new cosmetics not found elsewhere,” adds Keshav K. Singh, PhD, Scientific Founder of Yuva Biosciences.
